BLRX
BioLineRX
BLRX
BLRX
29 hedge funds and large institutions have $2.46M invested in BioLineRX in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more ownership
Funds ownership: 0% → 0% (+0%)
11% less call options, than puts
Call options by funds: $635K | Put options by funds: $715K
Holders
29
Holding in Top 10
–
Calls
$635K
Puts
$715K
Top Buyers
| 1 | +$382K | |
| 2 | +$279K | |
| 3 | +$88K | |
| 4 |
RG
Rathbones Group
Liverpool,
United Kingdom
|
+$72.5K |
| 5 |
AMBIA
Allen Mooney & Barnes Investment Advisors
Thomasville,
Georgia
|
+$45.5K |
Top Sellers
| 1 | -$280K | |
| 2 | -$157K | |
| 3 | -$155K | |
| 4 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$98.6K |
| 5 |
LPL Financial
San Diego,
California
|
-$20.9K |